|
|
|
| Data analysis of clinical transfusion in obstetrics |
| YAO Jie1 REN Wei1 YAN Yu1 CHEN Jinmei1 REN Yanli1 GAO Yan1 ZHANG Shujian2 ZHAO Zheng2 |
1.Department of Blood Transfusion, Xuanwu Hospital, Capital Medical University, Beijing 100053, China;
2.Department of Clinical Medicine, Capital Medical University, Beijing 100053, China |
|
|
|
|
Abstract Objective To provide evidence-based medical basis to improve the blood supply ability and safety stock level of blood transfusion in Department of Obstetrics, Xuanwu Hospital, Capital Medical University ("our hospital" for short) by analyzing clinical blood use and other data of blood transfusion for nearly 6 years. Methods Retrospective study was conducted by our hospital to analyze the data about clinical blood use of 15 498 obstetrical patients from January 2011 to December 2016, including component blood transfusion quantity, blood transfusion rate, massive blood transfusion rate, supreme value of massive blood transfusion and clinical information of massive blood transfusion patients. Results 229 of 15 498 patients had received blood transfusion, with the rate of 1.48%. Transfusion quantity, blood transfusion rate and massive blood transfusion annually decreased from 2011 to 2014, fell to 177 U, 0.70% and 0.03% in 2014. Since 2015, the index started to rise and reached 501 U, 2.28% and 0.40% by 2016. 29 patients had received red blood cell infusion more than 10 U. The supreme value of red blood cell infusion was 42 U in 2012, 24 U in 2015 and 20 U in 2016 respectively. Conclusion The transfusion quantity, blood transfusion rate and massive blood transfusion of blood transfusion department annually decreased from 2011 to 2014. An increase followed in 2015 and 2016. It Indicated an increase risk of clinic blood use and a decrease in supreme value of massive blood transfusion. The blood transfusion department should perform preoperative blood preparation in cooperation with the obstetrics to ensure the obstetrical medical safety.
|
|
|
|
|
|
[1] 李荣芳.全国大量输血现状调研协作组.中国部分地区三级综合医院不同科别外科大量输血现状调研[J].实验与检验医学，2015，33（5）：533-537.
[2] Ramler PI，van den Akker T，Henriquez DDCA，et al. Incidence，management and outcome of women requiring massive transfusion after childbirth in the Netherlands：secondary analysis of a nationwide cohort study between 2004 and 2006 [J]. BMC Pregnancy Childbirth，2017，17（1）：1384-1387.
[3] Butwock AJ，Ramachandran B，Hegde P，et al. Risk factors for severe postpartum hemorrhage after cesarean delivery：case-control studies [J]. Anesth Analg，2017，125（2）：1-8.
[4] 陈巍琳. 2014～2015年天柱县人民医院临床各科用血量分析[J].心理医生，2016，22（9）：234-235.
[5] 马星，刘军.产科手术采用回收式自体输血的研究进展[J].临床医药文献杂志，2016，3（41）：8289-8290.
[6] 潘纪春，王淑英，孙晓琳，等.某医院外科临床用血变化特征分析[J].临床输血与检验，2015，17（4）：301-305.
[7] 杨丽云，乐爱平.产科出血患者大量输血的相关研究[J].中国输血杂志，2013，26（9）：903-905.
[8] Munoz M，Pena-Rosas JP，Robinson S，et al. Patient blood management in obstetrics：management of anaemia and haematinic deficiencies in pregnancy and in the post-partum period：NATA consensus statement [J]. Transfus Med，2017，19（10）：12443-12461.
[9] 孙波，葛东梅，刘姣，等.智慧输血信息管理系统在围术期血液管理中的应用探讨[J].中国输血杂志，2017，30（5）：548-550.
[10] 高新强，谢东甫.持续推进血液管理水平促进临床科学合理用血[J].中华医学杂志，2014，94（7）：483-484.
[11] 佟艳.产后出血的高危因素研究分析[J].中国医药指南，2017，15（1）：64.
[12] 董丽.产科急性大出血患者成分输血的临床价值分析[J].基层医学论坛，2017，21（10）：1292-1293.
[13] Mousa HA，Blum J，Abou El Senoun G，et al. Treatment for primary postpartum haemorrhage [J]. Cochrane Database Syst Rev，2014，2（2）：CD003249.
[14] Biguzzi E，Franchi F，Acaia B，et al. Genetic backgroundand risk of postpartum haemorrhage：results from an Italiancohort of 3219 women [J]. Haemophilia，2014，20（6）：E377-E383.
[15] 高淑平.产后出血治疗研究进展[J].首都医药，2014，6：11-12.
[16] 何淑贞，曹金如，莫丽芳，等.妇产科住院患者红细胞输注效果评估[J].国际检验医学杂志，2016，37（16）：2318-2320.
[17] 吴梦思，王哲，胡清，王秋实.围产期输血相关因素分析[J].中国输血杂志，2011，24（2）：131-132.
[18] 赵金辉，王晨娜，庄太凤. 109例产后出血孕妇及新生儿高危因素的相关性分析[J].临床与病理杂志，2016， 36（9）：1409-1412.
[19] 王洁，杨庆忠.孕期不规则抗体筛查的临床意义分析[J].实验与检验医学，2016，34（6）：808-809.
[20] 黄春妍，魏曾珍，谭金哲，等. 360例紧急输血预案病例的输血情况分析[J].中国输血杂志，2017，30（4）：379-381.
[21] 中国医师协会输血科医师分会，中华医学会临床输血学分会.特殊情况紧急抢救输血推荐方案[J].中国输血杂志，2014，27（1）：1-3. |
|
|
|
